At what age do young people start using illicit drugs?
In 2022–2023, the average age at which people first tried any illicit drug was 19.5 years. This was younger than the age of initiation in 2019 (19.9 years) but has increased overall since 2001 (18.6 years). The average age of initiation has increased since 2001 for a range of drugs including cannabis, cocaine, hallucinogens and inhalants (AIHW 2024b, Table 5.17).
The 18th HILDA Survey report includes data on people who started using illicit drugs between 2017 and 2021, including people who may have resumed using drugs after previously stopping (Wilkins et al. 2024). These data show that around 1 in 5 people (19.0%) aged 20–24 started (or resumed) illicit drug use between 2017 and 2021, higher than any other age group.
Cannabis
Estimates from the NDSHS show that people aged 18–24 continue to be the most likely age group to use cannabis. Cannabis is the most widely used drug among this age group (AIHW 2024b). In 2022–2023, one-quarter (26%) of people in this age group had used cannabis in the past 12 months, compared with 11.5% of people aged 14 and over (AIHW 2024b, Table 5.50). However, recent use of cannabis has declined among this cohort since 2001 (32%) but remained stable between 2019 (25%) and 2022–2023 (AIHW 2024b).
In 2022–2023, 9.7% of people aged 14–17 had recently used cannabis. This represents a decrease from 21% in 2001, and a slight increase from 8.2% in 2019 (AIHW 2024b, Table 5.50).
The ASSAD survey reported that:
- In 2022–2023, 6.6% of students aged 12–17 had used cannabis in the month before the survey and 13.4% reported using cannabis in their lifetime, making cannabis the most commonly used drug in this cohort (Scully et al. 2023b, Table 6).
- There was a decrease in the proportion of young people aged 16–17 who had used cannabis both in their lifetime (30% in 2017 compared with 24% in 2022–2023) in the past month (15.7% in 2017 compared with 11.3% in 2022–2023) (Scully et al. 2023b, Figure 14).
Stimulants
Younger people are generally less likely to have used methamphetamine or amphetamine in their lifetime than those in older age groups, but recent use is similar. Estimates from the 2022–2023 NDSHS showed that:
- 3.6% of people aged 18–24 had used methamphetamine or amphetamine in their lifetime and 1.7% had done so in the previous 12 months (AIHW 2024b, tables 5.81 and 5.83).
- 3 in 5 (68%) people aged 18–24 who had used methamphetamine or amphetamine in the last 12 months had done so only once or twice (AIHW 2024b, Table 5.87).
By comparison, 12% of people in their 30s and 15% of people in their 40s had used methamphetamine or amphetamine in their lifetime, while 1.5% and 1.7% reported use in the previous 12 months (AIHW 2024b, tables 5.81 and 5.83). Conversely, recent use was less common among people aged in their 50s and over.
Recent use of cocaine and ecstasy has changed since 2019. The 2022–2023 NDSHS estimates suggest that among people aged 18–24:
- recent use of cocaine increased from 2019 (10.8%) to 2022–2023 (11.3%), with a substantial increase among females (8.0% to 11.9%) (AIHW 2024b, Table 5.65)
- recent use of ecstasy has been fluctuating since 2001 (11.7%), but decreased from 2019 (10.8%) to 2022–2023 (6.7%) (AIHW 2024b, Table 5.73). This is likely due to disruptions in ecstasy markets between 2019 and 2022 and the impact of COVID-19 restrictions on occasions for ecstasy use (for example, fewer dance parties and raves) (AIHW 2024b).
Findings from the 2022–2023 ASSAD survey reveal similar results. Of secondary school students aged 12–17, 1.7% have tried amphetamines, 1.9% have tried cocaine and 3.2% have tried ecstasy (Scully et al. 2023b, Table 7).
Other drugs
Other drugs that are used by young people include inhalants, hallucinogens, ketamine, new and emerging psychoactive substances, and tranquilisers and other pharmaceuticals for non-medical purposes (AIHW 2024b, Scully et al. 2023b). The 2022–2023 ASSAD survey showed that, among students aged 12–17:
- around 1 in 5 (18.0%) students had ever used tranquilisers for a non-medical reason and 5.6% had used them in the past month (Scully et al. 2023, Table 5). This is higher than 2022–2023 NDSHS estimates (*2.0% for lifetime use among people aged 14–17, and less than 1% for use in the past 12 months) (AIHW 2024b)
- 20% of students had deliberately sniffed inhalants at least once in their lifetime, with 7.4% reporting doing so in the past month (Scully et al. 2023b, Table 7)
- 2% of students reported they had used synthetic cannabis in the last 12 months (Scully et al. 2023b).
* Estimate has a relative standard error of 25% to 50% and should be used with caution.
Additionally, the NDSHS has showed that use of certain drugs among younger people aged 18–24 has increased over time (AIHW 2024b). Specifically:
- Use of ketamine rose from 1.6% in 2016 to 4.6% in 2022–2023.
- The proportion of people who have recently used hallucinogens has fluctuated over time, with 6.4% of those aged 18–24 reporting recent use in 2022–2023 (AIHW 2024b, Table 5.97).
For related content on illicit drug use in this report, see Drug types.
Does alcohol and other drug use vary by geographic area?
NDSHS data indicate that the proportion of young adults aged 18–24 who smoke tobacco daily or drink alcohol at risky levels has decreased across most states and territories since the early 2000s, but this varies by jurisdiction (AIHW 2024b). The proportion of 18–24-year-olds who reported recent illicit drug use has fluctuated over time and within jurisdictions.
For detailed information on alcohol and other drug use by state and territory in the NDSHS, see State and Territory summaries of alcohol, tobacco, e-cigarette and other drug use.
For related content on alcohol and other drug use by geographic areas in this report, see Geographic areas.
What do we know about health and harms among children and young people who use alcohol and other drugs?
Burden of disease related to alcohol and other drugs